Suppliers linked to impure heparin
The Food and Drug Administration said Wednesday it found 14 additional Chinese companies supplied contaminated raw material to make heparin, a widely used blood thinner. The companies supplied the materials in 2008, when the FDA found a link between contaminated heparin marketed by Baxter International Inc. to some Chinese suppliers of the active ingredient used in heparin. The contamination was linked to 80 deaths in U.S. patients and hundreds of allergic reactions. The same contamination was found in heparin sold by other pharmaceutical companies in other countries. An estimated 12 million Americans use heparin each year.
- How Top-Ranked MA Plans Earn Their Stars
- Readmissions: No Quick Fix to Costly Hospital Challenge
- How Hospitals Can Become 'Upstreamists'
- 4 Ways to Lower the Cost to Collect from Self-Pay Patients
- WellPoint Dominates Nearly Half of Markets, AMA Says
- 4 Tips for Managing Employed Physicians
- CMS Offers Some ACOs $114M for 'Upfront' Costs
- House Calls Key to Pioneer ACO Success
- Ebola: Second TX Nurse Diagnosed After Improper Protective Gear Application
- How Telehealth Pays Off for Providers, Patients